Ogatis, Gracenil Joy .

HRN: 18-26-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2026
CEFTAZIDIME 1GM (VIAL)
06/03/2026
06/10/2026
IV
2G
Q8HRS
PERIORBITAL CELLULITIS
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: